• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HS-1793通过干扰p53与MDM2之间的相互作用来抑制肺癌细胞的增殖。

HS-1793 inhibits cell proliferation in lung cancer by interfering with the interaction between p53 and MDM2.

作者信息

Lim Chungun, Lee Peter C W, Shim Sungbo, Jang Sung-Wuk

机构信息

Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea.

Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea.

出版信息

Oncol Lett. 2022 Jul 1;24(2):290. doi: 10.3892/ol.2022.13410. eCollection 2022 Aug.

DOI:10.3892/ol.2022.13410
PMID:35928802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9344265/
Abstract

The transcription factor or tumor suppressor protein p53 regulates numerous cellular functions, including cell proliferation, invasion, migration, senescence and apoptosis, in various types of cancer. HS-1793 is an analog of resveratrol, which exhibits anti-cancer effects on various types of cancer, including breast, prostate, colon and renal cancer, and multiple myeloma. However, to the best of our knowledge, the role of HS-1793 in lung cancer remains to be examined. The present study aimed to investigate the anti-cancer effect of HS-1793 on lung cancer and to determine its association with p53. The results revealed that HS-1793 reduced cell proliferation in lung cancer and increased p53 stability, thereby elevating the expression levels of the target genes p21 and mouse double minute 2 homolog (MDM2). When the levels of MDM2, a negative regulator of p53, are increased under normal conditions, MDM2 binds and degrades p53; however, HS-1793 inhibited this binding, confirming that p53 protein stability was increased. In conclusion, the findings of the present study provide new evidence that HS-1793 may inhibit lung cancer proliferation by disrupting the p53-MDM2 interaction.

摘要

转录因子或肿瘤抑制蛋白p53在各类癌症中调节众多细胞功能,包括细胞增殖、侵袭、迁移、衰老和凋亡。HS-1793是白藜芦醇的类似物,对包括乳腺癌、前列腺癌、结肠癌、肾癌和多发性骨髓瘤在内的多种癌症均具有抗癌作用。然而,据我们所知,HS-1793在肺癌中的作用仍有待研究。本研究旨在探讨HS-1793对肺癌的抗癌作用,并确定其与p53的关联。结果显示,HS-1793可降低肺癌细胞的增殖,并增加p53的稳定性,从而提高靶基因p21和小鼠双微体2同源物(MDM2)的表达水平。在正常情况下p53的负调节因子MDM2水平升高时,MDM2会结合并降解p53;然而,HS-1793抑制了这种结合,证实p53蛋白稳定性增加。总之,本研究结果提供了新的证据,表明HS-1793可能通过破坏p53-MDM2相互作用来抑制肺癌增殖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4aa/9344265/aaceb5394f44/ol-24-02-13410-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4aa/9344265/1557d3fe77cb/ol-24-02-13410-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4aa/9344265/9398ef9461c7/ol-24-02-13410-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4aa/9344265/47f6c414a7c0/ol-24-02-13410-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4aa/9344265/2e643c5f3333/ol-24-02-13410-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4aa/9344265/aaceb5394f44/ol-24-02-13410-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4aa/9344265/1557d3fe77cb/ol-24-02-13410-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4aa/9344265/9398ef9461c7/ol-24-02-13410-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4aa/9344265/47f6c414a7c0/ol-24-02-13410-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4aa/9344265/2e643c5f3333/ol-24-02-13410-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4aa/9344265/aaceb5394f44/ol-24-02-13410-g04.jpg

相似文献

1
HS-1793 inhibits cell proliferation in lung cancer by interfering with the interaction between p53 and MDM2.HS-1793通过干扰p53与MDM2之间的相互作用来抑制肺癌细胞的增殖。
Oncol Lett. 2022 Jul 1;24(2):290. doi: 10.3892/ol.2022.13410. eCollection 2022 Aug.
2
Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.miR-660 在肺癌患者中表达下调,其替代物通过靶向 MDM2-p53 相互作用抑制肺肿瘤发生。
Cell Death Dis. 2014 Dec 11;5(12):e1564. doi: 10.1038/cddis.2014.507.
3
L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells.L-GILZ与p53和MDM2结合,并通过激活p53来抑制人类癌细胞中的肿瘤生长。
Cell Death Differ. 2015 Jan;22(1):118-30. doi: 10.1038/cdd.2014.129. Epub 2014 Aug 29.
4
MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.微小RNA-340通过靶向MDM2-p53信号通路抑制前列腺癌细胞的增殖和转移。
Oncol Rep. 2016 Feb;35(2):887-95. doi: 10.3892/or.2015.4458. Epub 2015 Nov 26.
5
Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer.一种特定的MDM2拮抗剂(MI-43)使p53重新激活,导致p21介导的细胞周期停滞以及结肠癌中的选择性细胞死亡。
Mol Cancer Ther. 2008 Jun;7(6):1533-42. doi: 10.1158/1535-7163.MCT-08-0140.
6
Slug promotes p53 and p21 protein degradation by inducing Mdm2 expression in HCT116 colon cancer cells.在HCT116结肠癌细胞中,Slug通过诱导Mdm2表达促进p53和p21蛋白降解。
Oncol Lett. 2021 Sep;22(3):681. doi: 10.3892/ol.2021.12942. Epub 2021 Jul 23.
7
Emerging Role of MDM2 as Target for Anti-Cancer Therapy: A Review.MDM2作为抗癌治疗靶点的新作用:综述
Ann Clin Lab Sci. 2016 Dec;46(6):627-634.
8
Efficient activation of p53 pathway in A549 cells exposed to L2, a novel compound targeting p53-MDM2 interaction.在 A549 细胞中,新型化合物 L2 靶向 p53-MDM2 相互作用,可有效激活 p53 通路。
Anticancer Drugs. 2009 Jul;20(6):416-24. doi: 10.1097/cad.0b013e32832aa7b0.
9
Ras homolog gene family, member A promotes p53 degradation and vascular endothelial growth factor-dependent angiogenesis through an interaction with murine double minute 2 under hypoxic conditions.在低氧条件下,Ras 同源基因家族成员 A 通过与鼠双微体 2 的相互作用促进 p53 降解和血管内皮生长因子依赖性血管生成。
Cancer. 2012 Sep 1;118(17):4105-16. doi: 10.1002/cncr.27393. Epub 2012 Jan 3.
10
Bibenzyl analogue DS-1 inhibits MDM2-mediated p53 degradation and sensitizes apoptosis in lung cancer cells.二苄基类似物 DS-1 抑制 MDM2 介导的 p53 降解并增强肺癌细胞的凋亡。
Phytomedicine. 2021 May;85:153534. doi: 10.1016/j.phymed.2021.153534. Epub 2021 Mar 11.

引用本文的文献

1
Unveiling the potential of HS-1793: a review of its anticancer properties and therapeutic promise.揭示HS-1793的潜力:对其抗癌特性及治疗前景的综述
Future Med Chem. 2024;16(21):2301-2311. doi: 10.1080/17568919.2024.2424150. Epub 2024 Nov 18.
2
Resveratrol in the Treatment of Gynecological Cancer: Mechanisms and Therapeutic Potential.白藜芦醇在妇科癌症治疗中的作用机制及治疗潜力
Curr Med Chem. 2024 May 3. doi: 10.2174/0109298673290941240430171146.
3
Therapeutic Effect of Resveratrol and its Novel Formulations on Lung Cancer: Focus on Biological Aspects and Underlying Pathways.

本文引用的文献

1
Neoadjuvant and Adjuvant Systemic Therapy for Early-Stage Non-small-Cell Lung Cancer.早期非小细胞肺癌的新辅助和辅助全身治疗。
Drugs. 2022 Jun;82(8):855-863. doi: 10.1007/s40265-022-01721-3. Epub 2022 May 21.
2
Strengths and pitfalls of brigatinib in non-small cell lung cancer patients' management.布加替尼在非小细胞肺癌患者管理中的优势和缺陷。
Minerva Med. 2022 Apr;113(2):315-332. doi: 10.23736/S0026-4806.21.07693-X.
3
Lung Metastases: Current Surgical Indications and New Perspectives.肺转移瘤:当前的手术指征及新观点
白藜芦醇及其新型制剂治疗肺癌的疗效:聚焦生物学方面及潜在作用机制。
Curr Med Chem. 2024;31(27):4340-4361. doi: 10.2174/0109298673266259231229050937.
4
P53/MDM2 Complex-Based Targeted Strategies in Colon Adenocarcinoma.P53/MDM2 复合物为基础的结肠癌靶向策略。
Acta Med Acad. 2023 Apr;52(1):24-29. doi: 10.5644/ama2006-124.398.
5
Involvement of AMPKα and MAPK-ERK/-JNK Signals in Docetaxel-Induced Human Tongue Squamous Cell Carcinoma Cell Apoptosis.AMPKα 和 MAPK-ERK/-JNK 信号在多西紫杉醇诱导的人舌鳞癌细胞凋亡中的作用。
Int J Mol Sci. 2022 Nov 10;23(22):13857. doi: 10.3390/ijms232213857.
Front Surg. 2022 Apr 29;9:884915. doi: 10.3389/fsurg.2022.884915. eCollection 2022.
4
Therapeutics Targeting p53-MDM2 Interaction to Induce Cancer Cell Death.靶向 p53-MDM2 相互作用的治疗方法诱导癌细胞死亡。
Int J Mol Sci. 2022 Apr 30;23(9):5005. doi: 10.3390/ijms23095005.
5
Small-molecule MDM2 inhibitors in clinical trials for cancer therapy.用于癌症治疗临床试验的小分子MDM2抑制剂
Eur J Med Chem. 2022 Jun 5;236:114334. doi: 10.1016/j.ejmech.2022.114334. Epub 2022 Apr 8.
6
Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?TP53 激活了许多细胞反应,其中哪些对肿瘤抑制至关重要?
Cell Death Differ. 2022 May;29(5):961-971. doi: 10.1038/s41418-022-00996-z. Epub 2022 Apr 8.
7
The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review.鼠双微体 2(MDM2)癌蛋白在眼部疾病中的作用:综述。
Exp Eye Res. 2022 Apr;217:108910. doi: 10.1016/j.exer.2021.108910. Epub 2022 Jan 5.
8
Molecular Pathology of Lung Cancer.肺癌的分子病理学
Cold Spring Harb Perspect Med. 2022 Mar 1;12(3):a037812. doi: 10.1101/cshperspect.a037812.
9
Berbamine Inhibits Cell Proliferation and Migration and Induces Cell Death of Lung Cancer Cells via Regulating c-Maf, PI3K/Akt, and MDM2-P53 Pathways.小檗胺通过调节c-Maf、PI3K/Akt和MDM2-P53信号通路抑制肺癌细胞增殖、迁移并诱导其死亡。
Evid Based Complement Alternat Med. 2021 Jul 8;2021:5517143. doi: 10.1155/2021/5517143. eCollection 2021.
10
The roles and regulation of MDM2 and MDMX: it is not just about p53.MDM2 和 MDMX 的作用和调节:不仅仅是关于 p53。
Genes Dev. 2021 May 1;35(9-10):575-601. doi: 10.1101/gad.347872.120. Epub 2021 Apr 22.